GSK signs partnership with AI company to supercharge drug development 

GlaxoSmithKline has signed a multiyear partnership agreement with artificial intelligence-powered pathology company PathAI, according to an April 5 news release. 

Advertisement

The partnership will focus on accelerating drug development and scientific research in oncology and non-alcoholic steatohepatitis and will use PathAI’s digital pathology tools to do so. 

“We look forward to leveraging both PathAI’s expertise and models to advance GSK’s proprietary AI models and focus on designing better models to deliver improved treatment options for patients with cancer and NASH,” said Kim Branson, Global Head of Artificial Intelligence and Machine Learning at GSK said in the release.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.